Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

339 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Resistance to BRAF-targeted therapy in melanoma.
Sullivan RJ, Flaherty KT. Sullivan RJ, et al. Among authors: flaherty kt. Eur J Cancer. 2013 Apr;49(6):1297-304. doi: 10.1016/j.ejca.2012.11.019. Epub 2013 Jan 2. Eur J Cancer. 2013. PMID: 23290787 Review.
New molecular targets in melanoma.
Flaherty KT. Flaherty KT. Curr Opin Oncol. 2004 Mar;16(2):150-4. doi: 10.1097/00001622-200403000-00012. Curr Opin Oncol. 2004. PMID: 15075908 Review.
VEGFR-targeted therapy.
Flaherty KT. Flaherty KT. Clin Adv Hematol Oncol. 2005 May;3(5):371-2. Clin Adv Hematol Oncol. 2005. PMID: 16167010 No abstract available.
Innovations and challenges in melanoma: summary statement from the first Cambridge conference.
Atkins MB, Elder DE, Essner R, Flaherty KT, Gajewski TF, Haluska FG, Hwu P, Keilholz U, Kirkwood JM, Mier JW, Ross MI, Slingluff CL, Sondak VK, Sosman JA, Weinstock MA, King L. Atkins MB, et al. Among authors: flaherty kt. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2291s-2296s. doi: 10.1158/1078-0432.CCR-05-2560. Clin Cancer Res. 2006. PMID: 16609047
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
Eisen T, Ahmad T, Flaherty KT, Gore M, Kaye S, Marais R, Gibbens I, Hackett S, James M, Schuchter LM, Nathanson KL, Xia C, Simantov R, Schwartz B, Poulin-Costello M, O'Dwyer PJ, Ratain MJ. Eisen T, et al. Among authors: flaherty kt. Br J Cancer. 2006 Sep 4;95(5):581-6. doi: 10.1038/sj.bjc.6603291. Epub 2006 Aug 1. Br J Cancer. 2006. PMID: 16880785 Free PMC article. Clinical Trial.
339 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page